Trump's address, SpaceX IPO, Sam's Club membership prices and more in Morning Squawk

Oil jumped roughly 8% after President Trump said the U.S. could 'hit' Iran's oil and vowed to strike Iran 'extremely hard' over the next 2-3 weeks, sending stock futures lower in a clear risk-off move. SpaceX has confidentially filed for an IPO and could seek about a $1.75 trillion valuation with a potential June listing, while Eli Lilly received FDA approval for its once-daily GLP-1 pill Foundayo (shipping next week; $25/month with coupon or up to $349 without). Sam's Club raised annual membership by $10 to $60/$120 and Congressional Republicans backed a two-track DHS funding approach, leaving immigration enforcement for later debate.

Analysis

A geopolitical-driven risk repricing is compressing risk assets and widening energy-market implied volatility; that dynamic favors holders of oil optionality and penalizes short-duration, high-beta exposures over the next 2–6 weeks when headline noise and thin holiday liquidity amplify gap risk. Second-order, higher energy transport and logistics costs will feed into grocery and discretionary margins with a 6–12 month lag — companies with membership/loyalty revenue (sticky, recurring cash flow) will see smaller churn versus basket-dependent retailers.

The GLP‑1 pill rollout accelerates channel bifurcation: DTC launch + couponing forces manufacturers to trade higher initial volume for lower realized net price, compressing near-term EBITDA per new patient but expanding total addressable market. That increases contestability for incumbents with differentiated economies of scale in manufacturing and payer contracting; expect market share battles to be decided by PBM formulary wins and rebate structures over 3–12 months, not just product efficacy headlines.

A marquee IPO from a capital-starved tech platform would reallocate institutional demand and could temporarily depress other late-stage tech valuations; rotation risk is acute during the IPO window as index-eligible flows, lockups, and Musk-linked correlated selling can create cross-asset liquidity squeezes. Separately, large-scale reallocation into AI R&D at legacy software vendors creates near-term margin risk but raises medium-term product stickiness — an asymmetric setup for active, event-driven trades.

Given the calendar (jobs data ahead, holiday-thinned markets) hedge instruments and calendar-sensitive option structures dominate efficient risk control. Key near-term catalysts to watch: payrolls and unemployment, DHS funding developments, and first month of GLP‑1 DTC sales data — each can swing sentiment materially within days but typically resolves into secular share-shifts over months.

Key Decisions for Investors

• Buy short-dated energy call spreads (e.g., XLE 30–45 day 1x1 call spread) to capture elevated crude volatility with defined risk. Target entry: within next 48 hours while implied vols remain elevated; position size 2–4% notional of tactical book. Reward: captures a ~15–40% up-move in energy ETF with limited downside to premium paid.
• Pairs trade GLP‑1 competition: Long LLY 6–9 month call (or buy-call spread) funded by selling NVO 6–9 month calls (strike slightly OTM) to express share-shift to Lilly while capping capital. Timeframe: 6–12 months to let formulary and payer reactions materialize. Risk: capped by sold calls; upside if Lilly converts DTC demand into durable payer wins.